日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug-Repurposing Screen Identifies Thiostrepton as a Novel Regulator of the Tumor Suppressor DAB2IP.

药物再利用筛选发现硫链丝菌素是肿瘤抑制因子 DAB2IP 的新型调节剂

De Florian Fania Rossella, Maiocchi Serena, Klima Raffaella, Rossin Monica, Pellegrini Valeria, Ghetti Sabrina, Selvestrel Davide, Mattevi Maria Chiara, Fava Luca L, Braga Luca, Collavin Licio

An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications

本文将更新RasGAP蛋白DAB2IP的抑癌功能,并重点探讨其治疗意义。

De Florian Fania, Rossella; Bellazzo, Arianna; Collavin, Licio

FSP1 is a predictive biomarker of osteosarcoma cells' susceptibility to ferroptotic cell death and a potential therapeutic target

FSP1 是骨肉瘤细胞对铁凋亡易感性的预测生物标志物,也是潜在的治疗靶点

Elzbieta Panczyszyn #, Valentina Saverio #, Romina Monzani, Mara Gagliardi, Jelena Petrovic, Jasmina Stojkovska, Licio Collavin, Marco Corazzari

Wild-type and mutant p53 in cancer-related ferroptosis. A matter of stress management?

野生型和突变型p53在癌症相关铁死亡中的作用。这与压力管理有关吗?

Corazzari, Marco; Collavin, Licio

The Tumor Suppressor DAB2IP Is Regulated by Cell Contact and Contributes to YAP/TAZ Inhibition in Confluent Cells

肿瘤抑制因子 DAB2IP 受细胞接触调控,并有助于融合细胞中的 YAP/TAZ 抑制

Mattia Apollonio, Arianna Bellazzo, Nicoletta Franco, Silvia Lombardi, Beatrice Senigagliesi, Loredana Casalis, Pietro Parisse, Agnes Thalhammer, Gabriele Baj, Rossella De Florian Fania, Giannino Del Sal, Licio Collavin

TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses

树突状细胞表达 TIM4 介导肿瘤相关抗原的吸收和抗肿瘤反应

Nicoletta Caronni #, Giulia Maria Piperno #, Francesca Simoncello, Oriana Romano, Simone Vodret, Yuichi Yanagihashi, Regine Dress, Charles-Antoine Dutertre, Mattia Bugatti, Pierre Bourdeley, Annalisa Del Prete, Tiziana Schioppa, Emilia Maria Cristina Mazza, Licio Collavin, Serena Zacchigna, Renato O

Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome

突变型p53诱导高尔基体小管囊泡化,驱动促转移分泌组。

Valeria Capaci ,Lorenzo Bascetta # ,Marco Fantuz # ,Galina V Beznoussenko ,Roberta Sommaggio ,Valeria Cancila ,Andrea Bisso ,Elena Campaner ,Alexander A Mironov ,Jacek R Wiśniewski ,Luisa Ulloa Severino ,Denis Scaini ,Fleur Bossi ,Jodi Lees ,Noa Alon ,Ledia Brunga ,David Malkin ,Silvano Piazza ,Licio Collavin ,Antonio Rosato ,Silvio Bicciato ,Claudio Tripodo ,Fiamma Mantovani ,Giannino Del Sal

miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway

miR-331-3p 通过抑制 MAPK 信号通路参与雷帕霉素逆转糖皮质激素耐药性

Marianna Lucafò, Daria Sicari, Andrea Chicco, Debora Curci, Arianna Bellazzo, Alessia Di Silvestre, Chiara Pegolo, Robert Autry, Erika Cecchin, Sara De Iudicibus, Licio Collavin, William Evans, Giuliana Decorti, Gabriele Stocco

Mutant p53 as a guardian of the cancer cell

突变型p53作为癌细胞的守护者

Mantovani, Fiamma; Collavin, Licio; Del Sal, Giannino

Complexes formed by mutant p53 and their roles in breast cancer

突变型p53形成的复合物及其在乳腺癌中的作用

Bellazzo, Arianna; Sicari, Daria; Valentino, Elena; Del Sal, Giannino; Collavin, Licio